Meta-Analysis
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 6052-6059
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.6052
Figure 1
Figure 1 Pooled analysis of the variant allele CD24-C170T in the IBD, UC, and Crohn’s disease subgroups. ORs and 95%CIs of the individual studies and pooled analysis of the associations between the CD24 C170T C allele and the disease risks for Crohn’s disease (CD) (OR = 1.16, 95%CI: 0.69-1.93), ulcerative colitis (UC) (OR = 1.49, 95%CI: 0.81-2.77), and inflammatory bowel disease (IBD) (OR = 1.39, 95%CI = 0.73-2.64). OR: Odds ratio.
Figure 2
Figure 2 Pooled analysis of the variant allele CD24 TG1527del in the IBD, UC and Crohn’s disease subgroups. ORs and 95%CIs of the individual studies and the pooled analysis of the associations between the CD24 TG1527del allele and the disease risks for Crohn’s disease (CD) (OR = 1.24, 95%CI: 1.01-1.52), ulcerative colitis (UC) (OR = 0.95, 95%CI: 0.76-1.19) and inflammatory bowel disease (IBD) (OR = 1.18, 95%CI: 0.99-1.41). OR: Odds ratio.